Apollomics Inc. SEC filings APLMW
Apollomics Inc. has 183 filings in SEC EDGAR's recent list, going back to Sep 14, 2022. Its latest annual report, Form 20-F, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 12, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Aug 11, 2026 |
| 6-K | Current report (foreign issuer) | Jul 21, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 14, 2026 | Jul 14, 2026 |
| 6-K | Current report (foreign issuer) | Jun 24, 2026 | Jun 24, 2026 |
| 6-K | Current report (foreign issuer) | Apr 27, 2026 | Apr 27, 2026 |
| 6-K | Current report (foreign issuer) | Apr 1, 2026 | Apr 1, 2026 |
| 6-K | Current report (foreign issuer) | Dec 22, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Dec 12, 2025 | Dec 11, 2025 |
| 6-K | Current report (foreign issuer) | Nov 19, 2025 | Nov 19, 2025 |
| 6-K | Current report (foreign issuer) | Nov 18, 2025 | Nov 17, 2025 |
| 6-K | Current report (foreign issuer) | Oct 21, 2025 | Oct 21, 2025 |
| 6-K | Current report (foreign issuer) | Oct 16, 2025 | Oct 15, 2025 |
| 6-K | Current report (foreign issuer) | Oct 14, 2025 | Oct 14, 2025 |
| 6-K | Current report (foreign issuer) | Sep 25, 2025 | Sep 25, 2025 |
| 6-K | Current report (foreign issuer) | Sep 5, 2025 | Sep 5, 2025 |
| 6-K | Current report (foreign issuer) | Sep 3, 2025 | Sep 3, 2025 |
| 6-K | Current report (foreign issuer) | Aug 28, 2025 | Aug 28, 2025 |
| 6-K | Current report (foreign issuer) | Jul 25, 2025 | Jul 25, 2025 |
| 6-K | Current report (foreign issuer) | Apr 3, 2025 | Apr 3, 2025 |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Dec 20, 2024 | Dec 20, 2024 |
| 6-K | Current report (foreign issuer) | Dec 10, 2024 | Dec 10, 2024 |
| 6-K | Current report (foreign issuer) | Nov 14, 2024 | Nov 14, 2024 |
| 6-K | Current report (foreign issuer) | Nov 1, 2024 | Nov 1, 2024 |
| 6-K | Current report (foreign issuer) | Aug 14, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 1, 2024 | Aug 1, 2024 |
| 6-K | Current report (foreign issuer) | Jul 16, 2024 | Jul 16, 2024 |
| 6-K | Current report (foreign issuer) | Jul 3, 2024 | Jul 3, 2024 |
| 6-K | Current report (foreign issuer) | May 24, 2024 | May 24, 2024 |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 25, 2024 | Apr 25, 2024 |
| 6-K | Current report (foreign issuer) | Mar 28, 2024 | Mar 28, 2024 |
| 6-K | Current report (foreign issuer) | Mar 4, 2024 | Mar 4, 2024 |
| 6-K | Current report (foreign issuer) | Jan 19, 2024 | Jan 19, 2024 |
| 6-K | Current report (foreign issuer) | Jan 8, 2024 | Jan 8, 2024 |
| 6-K | Current report (foreign issuer) | Sep 28, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jul 20, 2023 | Jul 20, 2023 |
| 6-K | Current report (foreign issuer) | Mar 30, 2023 | Mar 30, 2023 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APLM (Nasdaq), APLMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Covina, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1944885
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.